BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23711293)

  • 1. Prognostic impact of preoperative hematological disorders and a risk stratification model in bladder cancer patients treated with radical cystectomy.
    Sejima T; Morizane S; Yao A; Isoyama T; Saito M; Amisaki T; Koumi T; Takenaka A
    Int J Urol; 2014 Jan; 21(1):52-7. PubMed ID: 23711293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
    Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
    BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
    Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
    Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
    BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy.
    Yoshida T; Kinoshita H; Yoshida K; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Matsuda T
    Jpn J Clin Oncol; 2015 Dec; 45(12):1162-7. PubMed ID: 26423342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.
    Morizane S; Yumioka T; Yamaguchi N; Masago T; Honda M; Sejima T; Takenaka A
    Int Urol Nephrol; 2015 Aug; 47(8):1335-41. PubMed ID: 26104379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.
    Eisenberg MS; Boorjian SA; Cheville JC; Thompson RH; Thapa P; Kaushik D; Frank I
    J Urol; 2013 Dec; 190(6):2005-10. PubMed ID: 23770147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
    J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
    Rink M; Lee DJ; Kent M; Xylinas E; Fritsche HM; Babjuk M; Brisuda A; Hansen J; Green DA; Aziz A; Cha EK; Novara G; Chun FK; Lotan Y; Bastian PJ; Tilki D; Gontero P; Pycha A; Baniel J; Mano R; Ficarra V; Trinh QD; Tagawa ST; Karakiewicz PI; Scherr DS; Sjoberg DD; Shariat SF;
    BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.
    Harada K; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2005 Mar; 12(3):250-5. PubMed ID: 15828951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy.
    Nakagawa T; Hara T; Kawahara T; Ogata Y; Nakanishi H; Komiyama M; Arai E; Kanai Y; Fujimoto H
    J Urol; 2013 Apr; 189(4):1275-81. PubMed ID: 23123368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?
    Hong SK; Kwak C; Jeon HG; Lee E; Lee SE
    Urology; 2005 Apr; 65(4):697-702. PubMed ID: 15833511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy.
    Masson-Lecomte A; Vordos D; Hoznek A; Yiou R; Allory Y; Abbou CC; de la Taille A; Salomon L
    Ann Surg Oncol; 2013 Apr; 20(4):1389-94. PubMed ID: 23208127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of hydronephrosis in bladder cancer treated by radical cystectomy.
    Resorlu B; Baltaci S; Resorlu M; Ergun G; Abdulmajeed M; Haliloglu AH; Gogus C; Beduk Y
    Urol Int; 2009; 83(3):285-8. PubMed ID: 19829026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
    Cole CJ; Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):331-40. PubMed ID: 7751174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative hydronephrosis as an indicator of survival after radical cystectomy.
    Chapman DM; Pohar KS; Gong MC; Bahnson RR
    Urol Oncol; 2009; 27(5):491-5. PubMed ID: 18657452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
    J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.